Brief: Ys Biopharma And Summit Healthcare Announce Shareholder Approval Of Business Combination
14/03/2023 23:00
March 14 (Reuters) - Summit Healthcare Acquisition Corp
SMIH.O :
* YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER
APPROVAL
OF BUSINESS COMBINATION
Source text for Eikon: ID:nPn8PP51ba
Further company coverage: SMIH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing